title: Introduction: are current drug development programmes realising the full potential of new agents?
authors.affiliation: The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Chelsea, London, UK. Stephen.Johnston@rmh.nhs.uk
authors.forename: Stephen R D
authors.initials: SR
authors.lastname: Johnston
authors.forename: Ajay
authors.initials: A
authors.lastname: Bhatanager
mesh_terms: D015415:Biomarkers; D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D016172:DNA Fingerprinting; D055808:Drug Discovery; D005260:Female; D006801:Humans; D058990:Molecular Targeted Therapy
chemical_list: D015415:Biomarkers